![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, April 23, 2017 2:29:18 PM
In my opinion this is what is going on in the back ground.
Doctors who just want to use a patients stem cells for treatment do not want stem cells treated as a drug by the FDA. (USRM types)
Mesoblast is big pharma with their generic line and does not want individual stem cell use to succeed. They are aligned with Harvard, big investors like merril lynch and goldman sacs, and the big institutions that like expensive double blind trials.
RMAT will hopefully bypass a lot of the burocratic non sense in a sane effective way. There is a lot of the established heath industry threatened by it.
Have to see how this all plays out. Looks like this is a front row seat.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM